首页 | 本学科首页   官方微博 | 高级检索  
     


Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification
Authors:Jakub Trizuljak  Wolfgang R. Sperr  Lucie Nekvindová  Hanneke O. Elberink  Karoline V. Gleixner  Aleksandra Gorska  Magdalena Lange  Karin Hartmann  Anja Illerhaus  Massimiliano Bonifacio  Cecelia Perkins  Chiara Elena  Luca Malcovati  Anna B. Fortina  Khalid Shoumariyeh  Mohamad Jawhar  Roberta Zanotti  Patrizia Bonadonna  Francesca Caroppo  Alexander Zink  Massimo Triggiani  Roberta Parente  Nikolas von Bubnoff  Akif S. Yavuz  Hans Hägglund  Mattias Mattsson  Jens Panse  Nadja Jäkel  Alex Kilbertus  Olivier Hermine  Michel Arock  David Fuchs  Vito Sabato  Knut Brockow  Agnes Bretterklieber  Marek Niedoszytko  Björn van Anrooij  Andreas Reiter  Jason Gotlib  Hanneke C. Kluin-Nelemans  Jiri Mayer  Michael Doubek  Peter Valent
Affiliation:1. Department of Hematology and Oncology, University Hospital, CEITEC Masaryk University, Brno, Czech Republic;2. Department of Internal Medicine I, Division of Hematology and Hemostaseology, Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria;3. Institute of Biostatistics and Analyses, Ltd., Spinoff Company of Masaryk University, Brno, Czech Republic;4. Department of Allergology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands;5. Department of Allergology, Medical University of Gdańsk, Gdańsk, Poland;6. Department of Dermatology, Venereology and Allergology, Medical University of Gdańsk, Gdańsk, Poland;7. Division of Allergy, Department of Dermatology, University of Basel, Basel, Switzerland;8. Department of Dermatology, University of Cologne, Cologne, Germany;9. Department of Medicine, Section of Hematology, University of Verona, Verona, Italy;10. Division of Hematology, Department of Medicine, Stanford University, School of Medicine/Stanford Cancer Institute, Stanford, CA, USA;11. Division of Hematology, Fondazione IRCCS Policlinico San Matteo & University of Pavia, Pavia, Italy;12. Pediatric Dermatology Unit, Department of Medicine, University of Padova, Padova, Italy;13. Department of Hematology, Oncology and Stem Cell Transplantation, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany;14. Hämatologie und Onkologie, III. Medizinische Klinik, Universitätsmedizin Mannheim, Universität Heidelberg, Mannheim, Germany;15. Allergy Unit, Verona University Hospital, Verona, Italy;16. Department of Dermatology and Allergy Biederstein, School of Medicine, Technical University of Munich, Munich, Germany;17. Division of Allergy and Clinical Immunology, University of Salerno, Salerno, Italy;18. Division of Hematology, Istanbul Medical School, University of Istanbul, Istanbul, Turkey;19. Department of Medical Sciences, Uppsala University, Section of Hematology, Uppsala University Hospital, Uppsala, Sweden;20. Department of Oncology, Haematology, Haemostaseology and Stem Cell Transplantation, University Hospital RWTH Aachen, Aachen, Germany;21. Department of Internal Medicine IV, University Hospital Halle, Halle, Germany;22. Department of Dermatology and Venereology, Kepler University Hospital, Johannes Kepler University, Linz, Austria;23. Departement of Hematology, Centre National de Référence des Mastocytoses, Imagine Institute, INSERM U1123, Université Paris Descartes, Sorbonne, Paris Cité, Hôpital Necker, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France;24. Laboratory of Hematology, Pitié-Salpêtrière Hospital, Paris, France;25. Department of Internal Medicine 3, Hematology and Oncology, Kepler University Hospital, Johannes Kepler University, Linz, Austria;26. Faculty of Medicine and Health Sciences, Department of Immunology-Allergology-Rheumatology, University of Antwerp and Antwerp University Hospital, Antwerp, Belgium;27. Department of Dermatology and Venereology, Medical University of Graz, Graz, Austria;28. Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
Abstract:
Keywords:cutaneous mastocytosis  indolent systemic mastocytosis  prognostication  survival  WHO classification
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号